Oxford Asset Management’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-13,650
Closed -$1.07M 1254
2019
Q4
$1.07M Buy
+13,650
New +$1.01M 0.03% 823
2019
Q2
Sell
-22,640
Closed -$1.9M 1974
2019
Q1
$1.9M Buy
+22,640
New +$2.36M 0.04% 611
2018
Q4
Sell
-2,918
Closed -$354K 2126
2018
Q3
$354K Sell
2,918
-31,283
-91% -$3.88M 0.01% 1446
2018
Q2
$3.96M Buy
34,201
+20,141
+143% +$2.2M 0.08% 293
2018
Q1
$1.21M Buy
14,060
+4,978
+55% +$385K 0.03% 852
2017
Q4
$679K Sell
9,082
-15,957
-64% -$1.07M 0.01% 1089
2017
Q3
$1.45M Sell
25,039
-10,020
-29% -$592K 0.03% 786
2017
Q2
$2.25M Buy
35,059
+14,812
+73% +$913K 0.04% 550
2017
Q1
$1.17M Buy
+20,247
New +$1.21M 0.03% 738
2016
Q4
Sell
-24,080
Closed -$1.67M 870
2016
Q3
$1.67M Buy
+24,080
New +$1.59M 0.05% 436
2016
Q2
Sell
-4,236
Closed -$257K 880
2016
Q1
$257K Sell
4,236
-64,616
-94% -$3.8M 0.01% 694
2015
Q4
$4.45M Buy
68,852
+5,374
+8% +$349K 0.1% 210
2015
Q3
$4.25M Buy
63,478
+15,520
+32% +$1.1M 0.13% 153
2015
Q2
$3.28M Buy
47,958
+15,036
+46% +$954K 0.09% 254
2015
Q1
$1.83M Sell
32,922
-76,492
-70% -$3.92M 0.05% 380
2014
Q4
$5.66M Sell
109,414
-30,228
-22% -$1.48M 0.12% 176
2014
Q3
$5.1M Buy
139,642
+78,648
+129% +$2.84M 0.12% 176
2014
Q2
$2.38M Buy
+60,994
New +$2.26M 0.08% 342
2014
Q1
Sell
-93,802
Closed -$3.54M 776
2013
Q4
$3.54M Sell
93,802
-36,324
-28% -$1.39M 0.09% 312
2013
Q3
$5.65M Buy
130,126
+33,732
+35% +$1.35M 0.13% 205
2013
Q2
$3.49M Buy
+96,394
New +$2.93M 0.09% 350

Other funds holding USNA

Oxford Asset Management's USNA Position: Q1 2020 in Review

Oxford Asset Management sold out of Usana Health Sciences (USNA) in Q1 2020, closing a stake of 13,650 shares — an estimated $1.07M sold.

Oxford Asset Management first reported a position in USNA in Q2 2013 and held it in 21 quarters. The position peaked at $5.66M in Q4 2014. 169 funds tracked by Wall St. Rank hold USNA as of Q1 2020.

  • Oxford Asset Management reported no remaining Usana Health Sciences position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 13,650 Usana Health Sciences shares in Q1 2020, an estimated $1.07M.
  • Oxford Asset Management first reported a position in Usana Health Sciences in Q2 2013 and held it in 21 quarters.
  • Oxford Asset Management's Usana Health Sciences position peaked at $5.66M in Q4 2014.
  • 169 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.